The prevalence of lymphoedema in women who attended an information and exercise class to reduce the risk of breast cancer-related upper limb lymphoedema.
Identifieur interne : 000593 ( PubMed/Checkpoint ); précédent : 000592; suivant : 000594The prevalence of lymphoedema in women who attended an information and exercise class to reduce the risk of breast cancer-related upper limb lymphoedema.
Auteurs : E. Jeffs ; A. PurushothamSource :
- SpringerPlus [ 2193-1801 ] ; 2016.
Abstract
Breast cancer-related upper limb lymphoedema (BCRL) affects approximately 20 % of women undergoing axillary intervention. Women who attended a "reducing your risk of lymphoedema" class, including exercise instruction, anecdotally reported positive BCRL outcomes. The aim of this study was to examine BCRL outcomes and perceived benefit for attendees at a "reducing your risk of lymphoedema" class between 2000 and 2005. A cross-sectional study was conducted in two parts: (1) self-report questionnaire regarding lymphoedema status and benefit received from class and exercise programme; (2) clinical evaluation and objective measurement to confirm BCRL. 46 women completed questionnaires; 40 continued to clinical evaluation and objective measurement. BCRL prevalence defined as ≥10 % excess limb volume was only 5 %, although clinician judgement identified 23 % with arm lymphoedema and 8 % with lymphoedema limited to the hand. Clinician judgement correlated highly with patient self-report (Kappa = 0.833, p = 0.000). All women found the class beneficial, reporting increased confidence to return to normal life and a wide range of activities/exercise. We conclude that prevalence of BCRL should be determined by both clinical judgement and objective measurement to avoid underestimation. The benefit of group education with a lymphoedema expert and of exercise instruction should be further explored, and the potential for exercise to reduce BCRL prevalence should be examined.
DOI: 10.1186/s40064-015-1629-8
PubMed: 26759760
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:26759760Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The prevalence of lymphoedema in women who attended an information and exercise class to reduce the risk of breast cancer-related upper limb lymphoedema.</title><author><name sortKey="Jeffs, E" sort="Jeffs, E" uniqKey="Jeffs E" first="E" last="Jeffs">E. Jeffs</name><affiliation><nlm:affiliation>Florence Nightingale Faculty of Nursing and Midwifery, King's College London, James Clerk Maxwell Building, Waterloo Campus, 57 Waterloo Road, London, SE1 8WA UK.</nlm:affiliation><wicri:noCountry code="subField">SE1 8WA UK</wicri:noCountry></affiliation></author><author><name sortKey="Purushotham, A" sort="Purushotham, A" uniqKey="Purushotham A" first="A" last="Purushotham">A. Purushotham</name><affiliation><nlm:affiliation>Guy's and St Thomas NHS Foundation Trust, Guy's Hospital, 3rd Floor Bermondsey Wing, Great Maze Pond, London, SE1 9RT UK.</nlm:affiliation><wicri:noCountry code="subField">SE1 9RT UK</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:26759760</idno><idno type="pmid">26759760</idno><idno type="doi">10.1186/s40064-015-1629-8</idno><idno type="wicri:Area/PubMed/Corpus">000A56</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000A56</idno><idno type="wicri:Area/PubMed/Curation">000A56</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000A56</idno><idno type="wicri:Area/PubMed/Checkpoint">000A56</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000A56</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The prevalence of lymphoedema in women who attended an information and exercise class to reduce the risk of breast cancer-related upper limb lymphoedema.</title><author><name sortKey="Jeffs, E" sort="Jeffs, E" uniqKey="Jeffs E" first="E" last="Jeffs">E. Jeffs</name><affiliation><nlm:affiliation>Florence Nightingale Faculty of Nursing and Midwifery, King's College London, James Clerk Maxwell Building, Waterloo Campus, 57 Waterloo Road, London, SE1 8WA UK.</nlm:affiliation><wicri:noCountry code="subField">SE1 8WA UK</wicri:noCountry></affiliation></author><author><name sortKey="Purushotham, A" sort="Purushotham, A" uniqKey="Purushotham A" first="A" last="Purushotham">A. Purushotham</name><affiliation><nlm:affiliation>Guy's and St Thomas NHS Foundation Trust, Guy's Hospital, 3rd Floor Bermondsey Wing, Great Maze Pond, London, SE1 9RT UK.</nlm:affiliation><wicri:noCountry code="subField">SE1 9RT UK</wicri:noCountry></affiliation></author></analytic><series><title level="j">SpringerPlus</title><idno type="ISSN">2193-1801</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Breast cancer-related upper limb lymphoedema (BCRL) affects approximately 20 % of women undergoing axillary intervention. Women who attended a "reducing your risk of lymphoedema" class, including exercise instruction, anecdotally reported positive BCRL outcomes. The aim of this study was to examine BCRL outcomes and perceived benefit for attendees at a "reducing your risk of lymphoedema" class between 2000 and 2005. A cross-sectional study was conducted in two parts: (1) self-report questionnaire regarding lymphoedema status and benefit received from class and exercise programme; (2) clinical evaluation and objective measurement to confirm BCRL. 46 women completed questionnaires; 40 continued to clinical evaluation and objective measurement. BCRL prevalence defined as ≥10 % excess limb volume was only 5 %, although clinician judgement identified 23 % with arm lymphoedema and 8 % with lymphoedema limited to the hand. Clinician judgement correlated highly with patient self-report (Kappa = 0.833, p = 0.000). All women found the class beneficial, reporting increased confidence to return to normal life and a wide range of activities/exercise. We conclude that prevalence of BCRL should be determined by both clinical judgement and objective measurement to avoid underestimation. The benefit of group education with a lymphoedema expert and of exercise instruction should be further explored, and the potential for exercise to reduce BCRL prevalence should be examined.</div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">26759760</PMID><DateCreated><Year>2016</Year><Month>01</Month><Day>13</Day></DateCreated><DateCompleted><Year>2016</Year><Month>01</Month><Day>13</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2193-1801</ISSN><JournalIssue CitedMedium="Print"><Volume>5</Volume><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>SpringerPlus</Title><ISOAbbreviation>Springerplus</ISOAbbreviation></Journal><ArticleTitle>The prevalence of lymphoedema in women who attended an information and exercise class to reduce the risk of breast cancer-related upper limb lymphoedema.</ArticleTitle><Pagination><MedlinePgn>21</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40064-015-1629-8</ELocationID><Abstract><AbstractText>Breast cancer-related upper limb lymphoedema (BCRL) affects approximately 20 % of women undergoing axillary intervention. Women who attended a "reducing your risk of lymphoedema" class, including exercise instruction, anecdotally reported positive BCRL outcomes. The aim of this study was to examine BCRL outcomes and perceived benefit for attendees at a "reducing your risk of lymphoedema" class between 2000 and 2005. A cross-sectional study was conducted in two parts: (1) self-report questionnaire regarding lymphoedema status and benefit received from class and exercise programme; (2) clinical evaluation and objective measurement to confirm BCRL. 46 women completed questionnaires; 40 continued to clinical evaluation and objective measurement. BCRL prevalence defined as ≥10 % excess limb volume was only 5 %, although clinician judgement identified 23 % with arm lymphoedema and 8 % with lymphoedema limited to the hand. Clinician judgement correlated highly with patient self-report (Kappa = 0.833, p = 0.000). All women found the class beneficial, reporting increased confidence to return to normal life and a wide range of activities/exercise. We conclude that prevalence of BCRL should be determined by both clinical judgement and objective measurement to avoid underestimation. The benefit of group education with a lymphoedema expert and of exercise instruction should be further explored, and the potential for exercise to reduce BCRL prevalence should be examined.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jeffs</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Florence Nightingale Faculty of Nursing and Midwifery, King's College London, James Clerk Maxwell Building, Waterloo Campus, 57 Waterloo Road, London, SE1 8WA UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Purushotham</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Guy's and St Thomas NHS Foundation Trust, Guy's Hospital, 3rd Floor Bermondsey Wing, Great Maze Pond, London, SE1 9RT UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>01</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Springerplus</MedlineTA><NlmUniqueID>101597967</NlmUniqueID><ISSNLinking>2193-1801</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2010 Jul;17(7):1847-53</RefSource><PMID Version="1">20140528</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer. 2010 Dec;46(18):3211-8</RefSource><PMID Version="1">20797846</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann R Coll Surg Engl. 2003 May;85(3):158-61</RefSource><PMID Version="1">12831486</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2012 Oct 20;30(30):3726-33</RefSource><PMID Version="1">23008299</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphat Res Biol. 2005;3(4):208-17</RefSource><PMID Version="1">16379589</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Coll Surg. 2011 Oct;213(4):543-51</RefSource><PMID Version="1">21802319</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Phys Ther. 2001 Jun;81(6):1192-205</RefSource><PMID Version="1">11380275</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2013 Mar;46(1):1-11</RefSource><PMID Version="1">23930436</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Support Care Cancer. 2013 Apr;21(4):1013-23</RefSource><PMID Version="1">23073712</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nurs Res. 2003 Nov-Dec;52(6):370-9</RefSource><PMID Version="1">14639083</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Qual Life Res. 2013 Nov;22(9):2509-47</RefSource><PMID Version="1">23479209</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2006 Jun 20;24(18):2765-72</RefSource><PMID Version="1">16702582</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncol Nurs Forum. 2009 Jul;36(4):454-62</RefSource><PMID Version="1">19581236</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2013 May;14(6):500-15</RefSource><PMID Version="1">23540561</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2014 Oct;21(11):3481-9</RefSource><PMID Version="1">24809302</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphat Res Biol. 2011 Mar;9(1):13-8</RefSource><PMID Version="1">21417763</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1449-55</RefSource><PMID Version="1">19028274</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 2010 Jan 12;340:b5396</RefSource><PMID Version="1">20068255</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2012 Jun;133(2):667-76</RefSource><PMID Version="1">22286332</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Oncol Nurs. 2016 Feb;20:173-83</RefSource><PMID Version="1">26338435</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2009 Aug 13;361(7):664-73</RefSource><PMID Version="1">19675330</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 2010 Dec 22;304(24):2699-705</RefSource><PMID Version="1">21148134</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncol Nurs Forum. 1997 Jun;24(5):875-82</RefSource><PMID Version="1">9201739</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncol Nurs Forum. 2010 Jan;37(1):85-91</RefSource><PMID Version="1">20044343</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Treat Rev. 2008 Nov;34(7):621-8</RefSource><PMID Version="1">18691823</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J BUON. 2012 Jul-Sep;17(3):565-9</RefSource><PMID Version="1">23033300</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Psychooncology. 2013 Jul;22(7):1466-84</RefSource><PMID Version="1">23044512</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Phys Med Rehabil. 2006 Sep;87(9):1242-9</RefSource><PMID Version="1">16935062</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cochrane Database Syst Rev. 2015 Feb 13;(2):CD009765</RefSource><PMID Version="1">25677413</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2015 Jul;152(1):227-8</RefSource><PMID Version="1">25975953</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2005 Feb;89(3):221-6</RefSource><PMID Version="1">15754119</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2008 Mar;41(1):18-28</RefSource><PMID Version="1">18581955</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Lymphoedema. 2008;3(1):20-25</RefSource><PMID Version="1">25506390</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biometrics. 1977 Mar;33(1):159-74</RefSource><PMID Version="1">843571</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncologist. 2013;18(4):350-2</RefSource><PMID Version="1">23576481</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Oncol Nurs. 2006 Feb;10(1):71-9</RefSource><PMID Version="1">15936986</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2009 Apr 20;27(12):2007-14</RefSource><PMID Version="1">19289624</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2002 Sep;75(1):51-64</RefSource><PMID Version="1">12500934</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2014 Nov;148(2):249-68</RefSource><PMID Version="1">25324019</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Cancer Surviv. 2011 Dec;5(4):320-36</RefSource><PMID Version="1">22002586</PMID></CommentsCorrections></CommentsCorrectionsList><OtherID Source="NLM">PMC4703592</OtherID><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Breast cancer</Keyword><Keyword MajorTopicYN="N">Exercise</Keyword><Keyword MajorTopicYN="N">Lymphoedema</Keyword><Keyword MajorTopicYN="N">Prevalence</Keyword><Keyword MajorTopicYN="N">Risk reduction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>04</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>1</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>1</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>1</Month><Day>14</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26759760</ArticleId><ArticleId IdType="doi">10.1186/s40064-015-1629-8</ArticleId><ArticleId IdType="pii">1629</ArticleId><ArticleId IdType="pmc">PMC4703592</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list></list><tree><noCountry><name sortKey="Jeffs, E" sort="Jeffs, E" uniqKey="Jeffs E" first="E" last="Jeffs">E. Jeffs</name><name sortKey="Purushotham, A" sort="Purushotham, A" uniqKey="Purushotham A" first="A" last="Purushotham">A. Purushotham</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000593 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000593 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:26759760
|texte= The prevalence of lymphoedema in women who attended an information and exercise class to reduce the risk of breast cancer-related upper limb lymphoedema.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:26759760" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |